Detalhe da pesquisa
1.
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses.
Immunity
; 54(4): 769-780.e6, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33823129
2.
Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria.
N Engl J Med
; 390(17): 1549-1559, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669354
3.
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria.
N Engl J Med
; 387(5): 397-407, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921449
4.
Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.
J Infect Dis
; 220(11): 1802-1815, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31402384
5.
Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults.
Immun Ageing
; 14: 8, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28413427
6.
A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.
J Infect Dis
; 213(3): 411-22, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26259809
7.
Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS.
JCI Insight
; 9(7)2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587079
8.
TRAF6 is a T cell-intrinsic negative regulator required for the maintenance of immune homeostasis.
Nat Med
; 12(9): 1088-92, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16921377
9.
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.
Lancet Infect Dis
; 23(12): 1408-1417, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37544326
10.
Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial.
Lancet Respir Med
; 9(10): 1111-1120, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33864736
11.
A proof of concept for structure-based vaccine design targeting RSV in humans.
Science
; 365(6452): 505-509, 2019 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31371616
12.
A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age.
Vaccine
; 35(30): 3749-3759, 2017 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28579233
13.
Modeling maternal fetal RSV F vaccine induced antibody transfer in guinea pigs.
Vaccine
; 33(47): 6488-92, 2015 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26319066
14.
Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine.
Vaccine
; 31(3): 524-32, 2013 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23153449
15.
Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico.
Vaccine
; 29(44): 7826-34, 2011 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-21816199
16.
Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ regulatory T cells.
J Immunol
; 177(4): 2186-94, 2006 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16887978
17.
Homeostatic T cell proliferation as a barrier to T cell tolerance.
Philos Trans R Soc Lond B Biol Sci
; 360(1461): 1713-21, 2005 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-16147536